SCHEMBL10856480

SCHEMBL10856480

CC(=O)OC[C@H]1O[C@@H](c2csc3c(=S)[nH]cnc23)[C@H](OC(C)=O)[C@@H]1OC(C)=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.50
PTPN1 P18031 1/20 0.44
ALDH1A1 P00352 4/20 0.40
LMNA P02545 4/20 0.40
KDM4E B2RXH2 3/20 0.40
MAPT P10636 3/20 0.40
HPGD P15428 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
TP53 P04637 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
THRB P10828 2/20 0.40
HIF1A Q16665 1/20 0.40
NR3C1 P04150 1/20 0.38
FYN P06241 1/20 0.38
ADRA2A P08913 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
ADRA2B P18089 1/20 0.38
DRD4 P21917 1/20 0.38
DRD3 P35462 1/20 0.38
CA12 O43570 4/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10852042 0.89 TSHR (0.51) TSHRPTPN1ALDH1A1LMNAKDM4E
SCHEMBL11079766 0.72 LMNA (0.63) TSHRALDH1A1LMNAMAPTSMN1; SMN2
SCHEMBL14190561 0.71 TSHR (0.51) TSHRPTPN1ALDH1A1LMNAKDM4E
SCHEMBL6887836 0.71 TSHR (0.51) TSHRPTPN1ALDH1A1LMNAKDM4E
SCHEMBL6746376 0.71 TSHR (0.50) TSHRPTPN1ALDH1A1LMNAKDM4E
SCHEMBL6885574 0.71 TSHR (0.50) TSHRPTPN1ALDH1A1LMNAKDM4E
SCHEMBL11263625 0.70 TSHR (0.57) TSHRPTPN1ALDH1A1LMNAKDM4E
SCHEMBL11078327 0.70 ALDH1A1 (0.50) TSHRALDH1A1LMNAKDM4EMAPT
SCHEMBL14853762 0.69 TSHR (0.56) TSHRPTPN1ALDH1A1LMNASMN1; SMN2
SCHEMBL11626104 0.69 TSHR (0.56) TSHRPTPN1ALDH1A1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4584369-A ANTICANCER AGENTS SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1986-04-22 US disclosed
EP-0071227-A1 Anti-leukemic beta-glycosyl C-nucleosides Sloan-Kettering Institute For Cancer Research (US) 1983-02-09 EP disclosed